Stage III Small Intestinal Adenocarcinoma AJCC v8

general

Centers

Active Trials

—

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Stage IIIA Small Intestinal Adenocarcinoma AJCC v8	28	28

Top Centers for Stage III Small Intestinal Adenocarcinoma AJCC v8(28)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
2	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
3	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
4	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
5	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
6	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
7	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
8	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
9	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
10	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
11	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
12	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
13	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	2	—	51.8
14	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
15	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
16	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	2	—	51.8
17	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
18	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
19	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	2	—	51.8
20	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program	Active Research Program	2	—	51.8
21	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program	Active Research Program	2	—	51.8
22	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	2	—	51.8
23	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	2	—	51.8
24	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	2	—	51.8
25	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	2	—	51.8
26	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	2	—	51.8
27	The University of Vermont Cancer CenterBurlington, VT Active Research Program	Active Research Program	2	—	51.8
28	University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program	Active Research Program	2	—	51.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →